参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 海萝胶 | HCID 313 | — |
| 反应物 | 5-(4-氯苯基)糠醛 | HCID 676184 | — |
| 反应物 | HCID 15434827 | HCID 15434827 | — |
| 产物 | HCID 70277266 | HCID 70277266 | — |
反应步骤
5-(4-Chlorophenyl)-2-furancarboxaldehyde [prepared as described in U.S. Pat. No. 4,882,354, to Huang et al. (assigned to Norwich Eaton Pharmaceuticals, Inc.,) issued Nov. 21, 1984; see cols. 7 & 8, hereby incorporated by reference] (3.92 g, 19.0 mmole) and 3-amino-5-(1-piperidinyl)methyl-2-oxazolidinone (3.78 g, 19.0 mole)[(prepared as described in U.S. Pat. No. 2,802,002 to Gever, (assigned to Norwich Eaton Pharmaceuticals, Inc. issued Aug. 6, 1957, see Example I, Part A, hereby incorporated by reference herein) in 150 ml of alcohol is treated with 3 ml of concentrated hydrochloric acid (pH ca. 3). The reaction mixture is stirred and heated at reflux for 2.5 hours. The mixture is chilled and filtered to give crude 3-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-5-(1-piperidinylmethyl)-2-oxazolidinone hydrochloride, which is purified by one recrystallization from nitromethane (activated charcoal) yielding 3.2 g.
来源与证据
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 专利号 | US05994354 |
|---|
| 来源数据集 | uspto-grants-1999_11 |
|---|
| ORD ID | ord-951faccfe3e346afa14e1b4b803313b1 |
|---|
| 来源说明 | uspto-grants-1999_11 |
|---|